-
Alternative_name
RPR116258A, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate., XRP6258, TXD-258
-
Description
Cabazitaxel is a second generation semisynthetic taxane derived from 10-deacetylbaccatin with potent anticancer activity. Cabazitaxel binds to and stabilizes tubulin, resulting in the inhibition of microtubule depolymerization and cell division, cell cycle arrest in the G2/M phase, and the inhibition of tumor cell proliferation. Cabazitaxel is more potent than docetaxel (Cat. No. 2232) in P-glycoprotein-expressing cell lines with in vitro acquired resistance to taxanes or other chemotherapeutic agents.
-
CAS Number
183133-96-2
-
Structure Available
Yes
-
Molecular Formula
C₄₅H₅₇NO₁₄
-
Molecular Weight
835.93
-
Cell Permeable
True
-
Purity
≥98% by HPLC
-
Solubilities
Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
-
Handling
Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
-
Tag Line
A microtubule depolymerization inhibitor
-
Storage Condition
-20ºC
-
Shipping Condition
Gel Pack
-
Shelf Life
36 months
-
MDL Number
MFCD18827611
-
PubChem CID
9854073
-
-
SMILES
CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC
-
InChi
InChI=1S/C45H57NO14/c1-24-28(57-39(51)33(48)32(26-17-13-11-14-18-26)46-40(52)60-41(3,4)5)22-45(53)37(58-38(50)27-19-15-12-16-20-27)35-43(8,36(49)34(55-10)31(24)42(45,6)7)29(54-9)21-30-44(35,23-56-30)59-25(2)47/h11-20,28-30,32-35,37,48,53H,21-23H2,1-10H3,(H,46,52)/t28-,29-,30+,32-,33+,34+,35-,37-,43+,44-,45+/m0/s1
-
InChi Key
BMQGVNUXMIRLCK-OAGWZNDDSA-N
-
-
MSDS Available
True
